Levosimendan in burn wound ischemia: Mechanistic rationale and therapeutic potential
Open Access
- 25 May 2026
- Vol. 16, 33590
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Levosimendan increases brain tissue oxygen levels after cardiopulmonary resuscitation independent of cardiac function and cerebral perfusionScientific Reports, 2021
- Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseJournal of Cardiovascular Pharmacology, 2020
- Nicorandil reduces burn wound progression by enhancing skin blood flowJournal of Plastic, Reconstructive & Aesthetic Surgery, 2018
- Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in ratsDrug Design, Development and Therapy, 2018
- Levosimendan for the Prevention of Acute Organ Dysfunction in SepsisNew England Journal of Medicine, 2016
- Burn wound healing and treatment: review and advancementsCritical Care, 2015
- Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitroThrombosis and Haemostasis, 2015
- Beneficial Pharmacological Effects of Levosimendan on Antioxidant Status of Acute Inflammation Induced in Paw of Rat: Involvement in Inflammatory MediatorsBasic & Clinical Pharmacology & Toxicology, 2012
- Levosimendan Protection against Kidney Ischemia/Reperfusion Injuries in Anesthetized PigsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled studyCritical Care, 2010